Functional vision disorders in adults: a paradigm and nomenclature shift for ophthalmology.

Functional vision disorder SPIKES functional neurologic disorder functional visual loss medically unexplained vision loss non-organic vision loss psychogenic vision loss

Journal

Survey of ophthalmology
ISSN: 1879-3304
Titre abrégé: Surv Ophthalmol
Pays: United States
ID NLM: 0404551

Informations de publication

Date de publication:
Historique:
received: 30 01 2021
revised: 02 03 2021
accepted: 08 03 2021
pubmed: 20 3 2021
medline: 31 3 2022
entrez: 19 3 2021
Statut: ppublish

Résumé

Vision loss with clinical findings that are incompatible with the symptoms and recognized neurological or ophthalmic conditions is a common presentation of patients to neurologists, ophthalmologists, and neuro-ophthalmologists. The accepted terminology to describe such patients has evolved over time, including functional visual disorder (FVD), non-organic vision loss, non-physiologic vision loss, functional vision loss, psychogenic, psychosomatic, and medically unexplained visual loss. Likewise, attitudes and recommended management options have changed over the years in the fields of psychiatry and neurology. FVD is a diagnosis of inclusion, and it is critical that the diagnosis be made and delivered efficiently and effectively to reduce patient and physician duress. We review the current Diagnostic and Statistical Manual (DSM V) terminology and the prior literature on FVD and describe how the approaches to diagnosis and management have changed. We provide recommendations on the appropriate techniques and diagnostic approach for patients with FVD. We also propose a protocol for consistent and standardized discussion with the patient of the diagnosis of FVD. We believe that the adoption of FVD as both a paradigm and nomenclature shift in ophthalmology will improve patient care.

Identifiants

pubmed: 33737039
pii: S0039-6257(21)00075-8
doi: 10.1016/j.survophthal.2021.03.002
pmc: PMC9159904
mid: NIHMS1810647
pii:
doi:

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

8-18

Subventions

Organisme : NEI NIH HHS
ID : P30 EY026877
Pays : United States

Informations de copyright

Copyright © 2021. Published by Elsevier Inc.

Références

Curr Opin Ophthalmol. 2012 Nov;23(6):460-5
pubmed: 23047164
Arch Ophthalmol. 1983 May;101(5):729-35
pubmed: 6847460
Handb Clin Neurol. 2017;139:329-341
pubmed: 27719853
Neurol Clin. 1983 Nov;1(4):955-71
pubmed: 6390158
Postgrad Med J. 1999 Apr;75(882):201-7
pubmed: 10715758
Ophthalmology. 1987 Dec;94(12):1562-6
pubmed: 3431827
J Neurol Sci. 2017 Jan 15;372:144-151
pubmed: 28017202
Oncologist. 2000;5(4):302-11
pubmed: 10964998
Surv Ophthalmol. 1973 Jan-Feb;17(4):241-6
pubmed: 4802377
Gen Hosp Psychiatry. 2017 Mar - Apr;45:51-55
pubmed: 28274339
Continuum (Minneap Minn). 2014 Aug;20(4 Neuro-ophthalmology):785-815
pubmed: 25099095
Ophthalmology. 2001 Jan;108(1):76-80; discussion 80-1
pubmed: 11150267
Curr Opin Neurol. 2017 Apr;30(2):200-205
pubmed: 28141741
Ann Ophthalmol. 1988 Sep;20(9):335-9
pubmed: 3190112
Surv Ophthalmol. 2022 Jan-Feb;67(1):2-7
pubmed: 33338471
Gen Hosp Psychiatry. 1993 Mar;15(2):102-14
pubmed: 8472937
JAMA Neurol. 2018 Sep 1;75(9):1132-1141
pubmed: 29868890
Surv Ophthalmol. 2016 Nov - Dec;61(6):791-798
pubmed: 27134009
Neurol Clin. 1995 May;13(2):321-39
pubmed: 7643828
Am J Ophthalmol. 1985 Jul 15;100(1):209-13
pubmed: 4014374
Doc Ophthalmol. 1989 Sep;73(1):1-33
pubmed: 2698334
Ophthalmology. 1996 Jan;103(1):117-25
pubmed: 8628542
Ophthalmology. 2016 Jan;123(1):198-202
pubmed: 26481817
Arch Ophthalmol. 1979 May;97(5):865-6
pubmed: 444118
Ophthalmology. 2005 Oct;112(10):1821-8
pubmed: 16140382
Dement Neuropsychol. 2020 Dec;14(4):333-339
pubmed: 33354284
Doc Ophthalmol. 1992;82(4):369-82
pubmed: 1306483
Surv Ophthalmol. 1979 Sep-Oct;24(2):89-96
pubmed: 515946
Int J Ophthalmol. 2013 Oct 18;6(5):708-17
pubmed: 24195054
Am J Ophthalmol. 1974 Oct;78(4):722-4
pubmed: 4415892
Annu Rev Clin Psychol. 2014;10:25-51
pubmed: 24679178
Ophthalmol Clin North Am. 2004 Sep;17(3):321-8, vi
pubmed: 15337191
Neurol Clin. 2010 Aug;28(3):789-802
pubmed: 20638000
J Psychosom Res. 2016 Dec;91:55-60
pubmed: 27894463
Ophthalmology. 1985 Mar;92(3):427-35
pubmed: 3991130
Early Hum Dev. 2019 Dec;139:104841
pubmed: 31607402
Graefes Arch Clin Exp Ophthalmol. 2009 Jun;247(6):855-8
pubmed: 19089440
Ophthalmology. 1995 Jan;102(1):27-32
pubmed: 7831037
J Clin Neuroophthalmol. 1990 Jun;10(2):127-30
pubmed: 2141855
Acta Ophthalmol (Copenh). 1989 Apr;67(2):159-63
pubmed: 2728867
Neurology. 2008 Jan 15;70(3):218-21
pubmed: 18195266
J Clin Neurosci. 2007 Jan;14(1):1-7
pubmed: 16730991
Doc Ophthalmol. 1993;85(2):185-92
pubmed: 8082548
Int Ophthalmol Clin. 2019 Summer;59(3):141-152
pubmed: 31233421
Arch Ophthalmol. 1968 Mar;79(3):254-61
pubmed: 5640849
Handb Clin Neurol. 2017;139:73-84
pubmed: 27719879
Ophthalmology. 2002 Apr;109(4):810-5
pubmed: 11927447
Semin Neurol. 2015 Oct;35(5):557-63
pubmed: 26444401
Am J Ophthalmol. 2003 May;135(5):670-5
pubmed: 12719075
Handb Clin Neurol. 2019;160:481-493
pubmed: 31277870

Auteurs

Subahari Raviskanthan (S)

Department of Ophthalmology, Blanton Eye Institute, Houston Methodist Hospital, Houston, Texas, USA.

Sydney Wendt (S)

Baylor College of Medicine, Houston, Texas, USA.

Peter M Ugoh (PM)

Baylor College of Medicine, Houston, Texas, USA.

Peter W Mortensen (PW)

Department of Ophthalmology, Blanton Eye Institute, Houston Methodist Hospital, Houston, Texas, USA.

Heather E Moss (HE)

Department of Ophthalmology, Stanford University, Palo Alto, California, USA; Department of Neurology & Neurological Sciences, Stanford University, Palo Alto, California, USA.

Andrew G Lee (AG)

Department of Ophthalmology, Blanton Eye Institute, Houston Methodist Hospital, Houston, Texas, USA; Departments of Ophthalmology, Neurology, and Neurosurgery, Weill Cornell Medicine, New York, New York, USA; Department of Ophthalmology, University of Texas Medical Branch, Galveston, Texas, USA; University of Texas MD Anderson Cancer Center, Houston, Texas, USA; Texas A and M College of Medicine, Bryan, Texas, USA; Department of Ophthalmology, The University of Iowa Hospitals and Clinics, Iowa City, Iowa, USA. Electronic address: aglee@houstonmethodist.org.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH